STING1 and breast cancer: These findings show that the expression of Signature-3 genes is strongly associated with features of immunological hot tumors (30) and with a favorable prognosis in the TCGA breast cancer dataset, suggesting that PDS-dependent STING activation may elicit an antitumor immune response.